Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline

Author:

Shah Manish A.1,Kennedy Erin B.2,Catenacci Daniel V.3,Deighton Dana C.4,Goodman Karyn A.5,Malhotra Narinder K.6,Willett Christopher7,Stiles Brendon1,Sharma Prateek8,Tang Laura9,Wijnhoven Bas P. L.10,Hofstetter Wayne L.11

Affiliation:

1. New York Hospital/Weill Cornell Medical Center, New York, NY

2. American Society of Clinical Oncology, Alexandria, VA

3. University of Chicago Medicine, Chicago, IL

4. Alexandria, VA

5. Icahn School of Medicine at Mount Sinai, New York, NY

6. Yolanda G. Barco Cancer Institute, Meadville, PA

7. Duke Cancer Center, Durham, NC

8. University of Kansas School of Medicine and VAMC, Kansas City, KS

9. Memorial Sloan Kettering Cancer Center, New York, NY

10. Erasmus University Medical Center, Rotterdam, the Netherlands

11. The University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the more recently published literature (1999-2019) on therapy options for patients with locally advanced esophageal cancer and provide recommended care options for this patient population. RESULTS Seventeen randomized controlled trials met the inclusion criteria. Where possible, data were extracted separately for squamous cell carcinoma and adenocarcinoma. RECOMMENDATIONS Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended. For the subgroup of patients with adenocarcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered. For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy or chemoradiotherapy without surgery should be offered. Additional subgroup considerations are provided to assist with implementation of these recommendations. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines .

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3